Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The opioid epidemic is principally responsible for a recent increase in infective endocarditis in the United States.
The indication for AbbVie’s regimen includes those with compensated cirrhosis.
However, the presence of such persistent virus has not been found to be associated with liver damage.
Researchers call for greater use of noninvasive measures of fatty liver disease in this population to identify those at risk.
Inflammation in people with HIV is associated with cardiovascular disease and other serious health conditions.
Researchers analyzed autopsies among people with HIV who died in New York City since 1984.
Researchers analyzed the association between heavy drinking and immune function in those with untreated HIV.
Study finds the two types of stroke, ischemic and hemorrhagic, have different risk factors.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Researchers compared health outcomes among people with HIV, including those with and without hepatitis C.
Large European study finds that more than 1 in 10 people with HIV acquire HCV again.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
An NIH-sponsored peer-recruitment study is part of a larger push to figure out how to drive up the viral suppression rate in the U.S.
Pharmacists oversaw the delivery of hepatitis C treatment in a recent study.
European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.
A study of gay and bi men with HIV in Australia who had been cured of hep C found they associated hep C with injection drug use.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.